Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: A multicenter phase II trial
- 1 February 1999
- journal article
- clinical trial
- Published by Elsevier BV in Annals of Oncology
- Vol. 10 (2), 211-216
- https://doi.org/10.1023/a:1008315723253
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Advanced breast cancer: Investigational role of gemcitabineEuropean Journal Of Cancer, 1997
- Comparison of the antitumor activity of gemcitabine and ara-C in a panel of human breast, colon, lung and pancreatic xenograft modelsInvestigational New Drugs, 1996
- Advanced breast cancer: a phase II trial with gemcitabine.Journal of Clinical Oncology, 1995
- Paclitaxel activity in heavily pretreated breast cancer: a National Cancer Institute Treatment Referral Center trial.Journal of Clinical Oncology, 1995
- Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response.Journal of Clinical Oncology, 1995
- A Stopping Rule for Standard Chemotherapy for Metastatic Breast Cancer: Lessons from a Survey of Maryland Medical OncologistsCancer Investigation, 1994
- Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer.Journal of Clinical Oncology, 1993
- Difluorodeoxycytidine (dFdC) — gemcitabine: A phase I studyInvestigational New Drugs, 1992
- Comprehensive Criteria for Assessing Therapy-Induced ToxicityCancer Investigation, 1990
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958